Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioVaxys Technology Corp.
BVAXF
Primary Symbol:
C.BIOV
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical...
-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:BIOV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(328)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Feb 18, 2022 8:27am
GOOD MORNING BIOV REMEMBER CA MARKETS ARE CLOSED ON MONDAY
Schedule......If you are watching day screen trades, Brokers don't like to window dress over the weekend. (hold shares) That makes it a perfect day for CANADIANS TO BUY. This is 3 day weekend so
...more
(7)
•••
jeffa30
X
View Profile
View Bullboard History
Comment by
jeffa30
on Feb 17, 2022 11:18am
RE:CEO insider buying
https://www.canadianinsider.com/node/7?menu_tickersearch=BIOV+%7C+BioVaxys+Technology
QMET has 11 claims and 633 hectares Property in Ville-Marie, Quebec Hydrogen Camp
posted Nov 25, 2024 9:00am by
Q Precious & Battery Metals Corp.
-
|
The Company is pleased to discover that their Lorrain claims are now within the new and exciting exploration for hydrogen in the Ville-Marie, Lorrainville and Béarn region of Quebec. The region has undergone a claim staking rush following the ...read more
(7)
•••
jeffa30
X
View Profile
View Bullboard History
Post by
jeffa30
on Feb 17, 2022 11:16am
CEO insider buying
Filing Date Transaction Date Insider Name Ownership Type Securities Nature of transaction Volume or Value Price
...more
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Feb 16, 2022 10:59pm
https://www.mirrorreview.com/biovaxys-technology-corp/
https://www.mirrorreview.com/biovaxys-technology-corp/
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Feb 16, 2022 10:54pm
Interview
https://m.youtube.com/watch?v=6a4C5Tm_Kj4
(4)
•••
SnowBall123
X
View Profile
View Bullboard History
Comment by
SnowBall123
on Feb 16, 2022 5:55pm
RE:RE:RE:RE:RE:News BIOVAXYS ANNOUNCES complete inhibition of ACE-2 binding
what you guys talking about?
(328)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Feb 16, 2022 2:46pm
BIOV SAY HELLO @19 WE SHOULD TRADE IN @20's SOLID NEXT WEEK
ANYBODY GOT the new bi short session report?? shout out frankman!!<))
(12)
•••
frankman
X
View Profile
View Bullboard History
Comment by
frankman
on Feb 16, 2022 2:21pm
RE:RE:RE:RE:News BIOVAXYS ANNOUNCES complete inhibition of ACE-2 binding
Last response on TCF. It is not going to get done this month in my opinion. Maybe in March. No hurry as Russian navy is in Black Sea and rig is stuck in Romania (their nr) perhaps sub .20.
...more
(69)
•••
Humanist
X
View Profile
View Bullboard History
Comment by
Humanist
on Feb 16, 2022 1:38pm
RE:RE:RE:News BIOVAXYS ANNOUNCES complete inhibition of ACE-2 binding
Hi frankman, i am still holding as well, but my avg is much higher, what's your best guess for the low financing btw? i like the idea its shlumberger not a small unknown company, it gives me
...more
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Feb 16, 2022 1:02pm
Reminder if you still want to participate in the BIOV
financing contact the company website e mail and leave your number or try jpassin@biovaxys.com
(12)
•••
frankman
X
View Profile
View Bullboard History
Comment by
frankman
on Feb 16, 2022 12:11pm
RE:RE:News BIOVAXYS ANNOUNCES complete inhibition of ACE-2 binding
Hi Humanist If you remember I told you about TCF over a year ago. I still have shares. Many are going to be shocked by the low Trillion financing. Art is still pumping the stock. And I
...more
(69)
•••
Humanist
X
View Profile
View Bullboard History
Comment by
Humanist
on Feb 16, 2022 10:50am
RE:News BIOVAXYS ANNOUNCES complete inhibition of ACE-2 binding
REACTION IS A NON REACTION TO THE NEWS IT SEEMS. BTW FRANKMAN, TAKE A LOOK AT TCF..
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Feb 16, 2022 8:41am
News BIOVAXYS ANNOUNCES complete inhibition of ACE-2 binding
BIOVAXYS ANNOUNCES complete inhibition of ACE-2 binding activity of hapten-modified SARS-CoV-2 protein VANCOUVER, BC, Feb. 16, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE
...more
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Feb 15, 2022 9:15pm
Good job people almost fully subscribed tranche
For those participating CEO Passin is awaiting the final sub docs and wires
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario